About Us

Superna Life Sciences is a new specialty pharmaceutical company in the Canadian marketplace; but one that is deep in experience. Our team is made up of industry veterans experienced in the approval and commercialization of specialty products; in particular hematology and oncology products. Our goal is to utilize our expertise in regulatory affairs, distribution and commercialization in order to efficiently and successfully launch products into the Canadian health care market.

Founded in 2009 by co-founders Tom D’Orazio and Bruce Clarke, Superna is supported by a group of private investors. Amongst this predominantly industry-backed investor base are past and present executives of companies like: Genentech, QLT Inc, Schering-Plough and Pfizer, to name a few.